The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.00
Bid: 274.00
Ask: 278.00
Change: -7.00 (-2.51%)
Spread: 4.00 (1.46%)
Open: 273.00
High: 279.00
Low: 272.00
Prev. Close: 279.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

8 Feb 2024 07:00

RNS Number : 4068C
Fisher (James) & Sons plc
08 February 2024
 

8 February 2024

James Fisher and Sons plc

Full Year Trading Update

James Fisher and Sons plc (FSJ.L) ('James Fisher', 'the Group') today provides an update on trading for the year ended 31 December 2023, ahead of its Full Year Results.

Overview

Overall underlying trading in the second half was resilient and in line with market expectations. The Group has continued to make further early progress with its transformation during the period, focusing on operational improvements and simplification.

 

Divisional performance

 

Performance trends across all divisions through the second half were generally consistent with the first half. Energy market conditions remained largely supportive, underpinning strong performance in a number of divisional businesses, albeit North Sea IRM (inspection, repair and maintenance) and decommissioning conditions continued to be challenging. While revenue from larger project orders within Defence was lower than anticipated in the year, as procurement timelines were extended by customers, the division retains a solid pipeline and is still expected to deliver an improved year-on-year performance in 2023, underpinned by a focus on efficiency and effectiveness. The Maritime Transport division performed well with Tankships maintaining high tanker utilisation and stable day rates continuing for spot charter while Fendercare benefitted from increased operations in Brazil.

Transformation progress

 

The Group made further strategic progress in the second half to simplify and focus its portfolio, while improving overall financial performance. In December 2023, the Group ceased operations at Subtech Europe, which generated c.£40m of revenue in 2023. This business was incurring losses over a number of years because of increased competition and lower utilisation given the seasonality of the North Sea operations.

Further progress has been made on the Group's transformation projects that will strengthen organisational and operational capabilities. Ongoing costs of restructuring and refinancing together with costs of business closures mean that non-underlying cash costs for the second half are likely to be at a similar level to those reported in H1.

Financial position

 

The Group reduced its borrowings in the second half with pre-IFRS 16 net debt at 31 December 2023 reducing to £140m, from £147m at 30 June 2023 (£133m at 31 December 2022). The increase in net borrowing from 31 December 2022 reflects the additional financing and restructuring costs incurred in the year.

 

Jean Vernet, Chief Executive Officer, commented:

 

"With the steps we have taken to improve our operational and financial performance, I am encouraged by the progress across the three divisions. We are building the foundations for recovery and are seeing the benefits of the operational improvements being implemented. We remain fully committed to our ongoing portfolio simplification, which should further strengthen our balance sheet, as well as the investment in capability that will provide a platform for sustainable growth."

 

- Ends -

 

For further information:

James Fisher and Sons plc

Jean Vernet

Karen Hayzen-Smith

Chief Executive Officer

Chief Financial Officer

020 7614 9503

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUGWPUPCGBM
Date   Source Headline
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings
13th Feb 20245:50 pmRNSHolding(s) in Company
8th Feb 20247:00 amRNSFull Year Trading Update
25th Jan 20247:00 amRNSAppointment of Independent Non-Executive Director
20th Dec 20236:06 pmRNSNotification of Director’s Interests in Shares
15th Dec 20233:07 pmRNSBLOCK LISTING SIX MONTHLY RETURN
22nd Nov 20234:06 pmRNSHolding(s) in Company
9th Nov 20231:59 pmRNSBoard Changes
26th Oct 20237:30 amRNSDirector Declaration
2nd Oct 20239:00 amRNSTotal Voting Rights and Share Capital
25th Sep 202311:29 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHalf year results
3rd Aug 20237:00 amRNSAppointment of Chief Financial Officer
17th Jul 20237:01 amRNSBoard Change
17th Jul 20237:00 amRNSHalf year trading update
6th Jul 20237:00 amRNSHolding(s) in Company
15th Jun 20233:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Jun 20234:18 pmRNSResults of Annual General Meeting (“AGM”)
14th Jun 20237:00 amRNSAGM Trading Statement
12th Jun 20234:24 pmRNSNotification of Directors' Interests in Shares
9th Jun 20233:53 pmRNSNotification of Directors' Interest in Shares
7th Jun 20237:00 amRNSCompletion of refinancing
12th May 20234:49 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
2nd May 20237:00 amRNSUpdate on full year results
28th Apr 20237:58 amRNSFull year results for the year ended 31 Dec 2022
26th Apr 20237:00 amRNSAgreed Revolving Credit Facility
28th Mar 20232:00 pmRNSHolding(s) in Company
24th Mar 20237:00 amRNSCorporate, Financing and Trading Update
6th Mar 20237:00 amRNSSale of JFN, Trading Update and Notice of Results
28th Dec 20227:00 amRNSSwordfish Dive Support Vessel sold for US$24m
19th Dec 20227:00 amRNSDisposal of three businesses
15th Dec 20224:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
19th Oct 20229:14 amRNSHolding(s) in Company
13th Sep 202212:59 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSCompany Secretary Change
29th Jul 20224:39 pmRNSHolding(s) in Company
23rd Jun 20222:06 pmRNSHolding(s) in Company
17th Jun 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 20224:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jun 20227:00 amRNSCEO Update
6th May 20225:42 pmRNSHolding(s) in Company
5th May 20225:05 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Statement
25th Apr 20221:42 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSAnnual Report and Notice of 2022 AGM posted
22nd Mar 20224:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.